Ani Pharmaceuticals (ANIP) Shareholder Regent Investment Management Has Decreased Stake by $330,460 as Share Price Rose; Mgp Ingredients New (MGPI) Valuation Declined While Cardinal Capital Management Lowered Position

Regent Investment Management Llc decreased its stake in Ani Pharmaceuticals (ANIP) by 9.36% based on its latest 2019Q2 regulatory filing with the SEC. Regent Investment Management Llc sold 4,030 shares as the company’s stock rose 20.43% . The hedge fund held 39,009 shares of the health care company at the end of 2019Q2, valued at $3.21M, down from 43,039 at the end of the previous reported quarter. Regent Investment Management Llc who had been investing in Ani Pharmaceuticals for a number of months, seems to be less bullish one the $875.47M market cap company. The stock decreased 0.47% or $0.34 during the last trading session, reaching $72.37. About 91,460 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 25.49% since September 30, 2018 and is uptrending. It has outperformed by 25.49% the S&P500. Some Historical ANIP News: 18/04/2018 - ANI PHARMACEUTICALS REPORTS APPROVAL OF MORPHINE SULFATE ORAL; 27/04/2018 - ANI PHARMACEUTICALS SIGNS PACTS TO BUY GENERIC PRODUCTS, ASSETS; 27/04/2018 - U.S. FTC requires Amneal and lmpax to divest rights to 10 generic drugs; 27/04/2018 - ANI Pharmaceuticals, Amneal/Impax See Deal Closing in Early May; 27/04/2018 - FTC: ANI Pharmaceuticals to Acquire Seven Products; 18/04/2018 - ANI PHARMACEUTICALS INC - RECEIVED APPROVAL FROM U.S. FDA OF ITS ANDA FOR MORPHINE SULFATE ORAL SOLUTION 10MG/5ML, 20MG/5ML AND 100MG/5ML; 08/05/2018 - ANI Pharmaceuticals 1Q Adj EPS $1.32; 04/04/2018 - ANI BUYS 23 ANDAS FROM IDT AUSTRALIA,; 08/05/2018 - ANI Pharmaceuticals 1Q Rev $46.5M; 03/04/2018 IDT AUSTRALIA LTD IDT.AX - TO DIVEST A SELECTION OF ITS GENERIC PRODUCT PORTFOLIO TO ANI PHARMACEUTICALS INC

Cardinal Capital Management Llc decreased its stake in Mgp Ingredients Inc New (MGPI) by 17.93% based on its latest 2019Q2 regulatory filing with the SEC. Cardinal Capital Management Llc sold 37,520 shares as the company’s stock declined 26.26% . The institutional investor held 171,702 shares of the consumer non-durables company at the end of 2019Q2, valued at $11.39M, down from 209,222 at the end of the previous reported quarter. Cardinal Capital Management Llc who had been investing in Mgp Ingredients Inc New for a number of months, seems to be less bullish one the $852.61M market cap company. The stock decreased 1.18% or $0.6 during the last trading session, reaching $50.08. About 77,527 shares traded. MGP Ingredients, Inc. (NASDAQ:MGPI) has declined 38.35% since September 30, 2018 and is downtrending. It has underperformed by 38.35% the S&P500. Some Historical MGPI News: 09/05/2018 - MGP Ingredients Launches Rossville Union Master Crafted Straight Rye Whiskey, Adding to the Company’s Branded Portfolio; 02/05/2018 - MGP Ingredients Sees 2018 Net Sales Growth in the High Single-Digit Percentage Range Versus 2017; 21/04/2018 - DJ MGP Ingredients Inc, Inst Holders, 1Q 2018 (MGPI); 07/05/2018 - MGP Ingredients at Non-Deal Roadshow Hosted By SunTrust Today; 29/05/2018 - Factors of Influence in 2018, Key Indicators and Opportunity within Assembly Biosciences, MGP Ingredients, Globant S.A, 8point3; 23/04/2018 - MGP Takes Another Significant Step in Sustainability Efforts; Eliminates All Single Use Plastics at Company Facilities; 06/03/2018 TILL® American Wheat Vodka and George Remus® Bourbon Launch in Illinois with Breakthru Beverage; 17/04/2018 - TILL® American Wheat Vodka and George Remus® Bourbon Launch in Colorado with Breakthru Beverage; 16/05/2018 - MGP to Webcast Annual Meeting on May 23; 02/05/2018 - MGP Ingredients 1Q EPS 52c

Analysts await ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) to report earnings on November, 5. They expect $1.32 earnings per share, up 12.82% or $0.15 from last year’s $1.17 per share. ANIP’s profit will be $15.97M for 13.71 P/E if the $1.32 EPS becomes a reality. After $1.28 actual earnings per share reported by ANI Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 3.13% EPS growth.

Since May 15, 2019, it had 1 buying transaction, and 2 selling transactions for $4.76 million activity. Shares for $173,240 were bought by HAUGHEY THOMAS.

Investors sentiment increased to 1.96 in 2019 Q2. Its up 0.16, from 1.8 in 2019Q1. It is positive, as 8 investors sold ANIP shares while 41 reduced holdings. 29 funds opened positions while 67 raised stakes. 8.26 million shares or 10.11% more from 7.50 million shares in 2019Q1 were reported. Thb Asset Management reported 89,305 shares. Principal Financial Gp Incorporated has 0.01% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Metropolitan Life Insur Comm reported 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Fifth Third Retail Bank accumulated 4,945 shares. Oregon Pub Employees Retirement Fund invested in 3,312 shares or 0% of the stock. Rice Hall James And Assoc Limited Co reported 26,314 shares. Perkins Capital Mngmt Inc owns 29,800 shares. Wells Fargo & Mn stated it has 59,678 shares or 0% of all its holdings. Gsa Cap Prtn Ltd Liability Partnership holds 25,148 shares or 0.23% of its portfolio. Commonwealth Of Pennsylvania Pub School Empls Retrmt Systems invested in 0% or 2,886 shares. Brown Advisory owns 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 11,110 shares. Alliancebernstein LP holds 0% or 16,150 shares. Voya Invest Lc invested 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Raymond James Incorporated accumulated 0% or 2,694 shares. Shine Invest Advisory Svcs has invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP).

More notable recent ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) news were published by: Seekingalpha.com which released: “ANI Pharmaceuticals Q4 2018 Earnings Preview - Seeking Alpha” on February 26, 2019, also Nasdaq.com with their article: “ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know - Nasdaq” published on April 12, 2019, Seekingalpha.com published: “ANI Pharmaceuticals beats by $0.25, beats on revenue - Seeking Alpha” on May 09, 2019. More interesting news about ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) were released by: Benzinga.com and their article: “The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer’s Prostate Cancer Drug Passes FDA Muster - Benzinga” published on July 31, 2019 as well as Finance.Yahoo.com‘s news article titled: “ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance” with publication date: July 30, 2019.

Regent Investment Management Llc, which manages about $294.77 million and $307.41 million US Long portfolio, upped its stake in Merck & Co. Inc. (NYSE:MRK) by 4,265 shares to 52,487 shares, valued at $4.40M in 2019Q2, according to the filing. It also increased its holding in Qualcomm Inc (NASDAQ:QCOM) by 4,820 shares in the quarter, for a total of 9,312 shares, and has risen its stake in A T & T Inc (NYSE:T).

Analysts await MGP Ingredients, Inc. (NASDAQ:MGPI) to report earnings on November, 7. They expect $0.67 earnings per share, up 28.85% or $0.15 from last year’s $0.52 per share. MGPI’s profit will be $11.41M for 18.69 P/E if the $0.67 EPS becomes a reality. After $0.46 actual earnings per share reported by MGP Ingredients, Inc. for the previous quarter, Wall Street now forecasts 45.65% EPS growth.

Investors sentiment decreased to 1.56 in Q2 2019. Its down 0.11, from 1.67 in 2019Q1. It dived, as 17 investors sold MGPI shares while 35 reduced holdings. 15 funds opened positions while 66 raised stakes. 19.69 million shares or 1.41% more from 19.41 million shares in 2019Q1 were reported. Chilton Invest Co Ltd Liability Corp invested 0.04% of its portfolio in MGP Ingredients, Inc. (NASDAQ:MGPI). State Board Of Administration Of Florida Retirement Sys reported 18,330 shares. Utd Ser Automobile Association holds 0% or 6,587 shares. Sg Americas Securities Ltd Com accumulated 35,788 shares. Vanguard accumulated 0% or 913,858 shares. Laurion Cap LP holds 8,900 shares. Diversified invested in 4,925 shares or 0.02% of the stock. Ameritas Inv Ptnrs invested 0% of its portfolio in MGP Ingredients, Inc. (NASDAQ:MGPI). Ameriprise Financial, Minnesota-based fund reported 191,122 shares. Envestnet Asset Mngmt holds 0% or 4,001 shares. First Tru LP stated it has 5,153 shares or 0% of all its holdings. Nj State Employees Deferred Compensation Plan has invested 0.05% of its portfolio in MGP Ingredients, Inc. (NASDAQ:MGPI). Df Dent And holds 0.09% or 71,499 shares. Putnam Investments Ltd stated it has 0.01% of its portfolio in MGP Ingredients, Inc. (NASDAQ:MGPI). Country Club Tru Na invested 0.03% in MGP Ingredients, Inc. (NASDAQ:MGPI).

More notable recent MGP Ingredients, Inc. (NASDAQ:MGPI) news were published by: Globenewswire.com which released: “MGP Ingredients Declares $0.08 Quarterly Dividend Nasdaq:MGPI - GlobeNewswire” on November 01, 2018, also Globenewswire.com with their article: “Industry Veteran Scott Vanderpool Joins MGP Nasdaq:MGPI - GlobeNewswire” published on January 17, 2019, Globenewswire.com published: “MGP Ingredients Schedules Second Quarter 2019 Conference Call/Webcast for Wednesday, July 31 - GlobeNewswire” on July 17, 2019. More interesting news about MGP Ingredients, Inc. (NASDAQ:MGPI) were released by: Globenewswire.com and their article: “Former Congresswoman Lynn Jenkins Joins MGP Ingredients Board of Directors - GlobeNewswire” published on February 05, 2019 as well as Gurufocus.com‘s news article titled: “MGP Ingredients Gets Crushed With Revenue Miss - GuruFocus.com” with publication date: May 06, 2019.

Cardinal Capital Management Llc, which manages about $1.96 billion and $3.06 billion US Long portfolio, upped its stake in Invitation Homes Inc by 21,530 shares to 802,871 shares, valued at $21.46M in 2019Q2, according to the filing. It also increased its holding in Livent Corp by 337,701 shares in the quarter, for a total of 4.04 million shares, and has risen its stake in Viper Energy Partners Lp (NASDAQ:VNOM).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.